Global landscape of COVID-19 and epilepsy research: A bibliometric analysis

BackgroundA large number of papers regarding coronavirus disease 2019 (COVID-19) and epilepsy have been published since the declaration of the COVID-19 pandemic. However, there is no bibliometric analysis on these papers. In this study, we aimed to analyze the bibliometric characteristics of these p...

Full description

Bibliographic Details
Main Authors: Guangxin Wang, Lian Bai, Mingxue Zhao, Shumei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.1034070/full
_version_ 1811235353729695744
author Guangxin Wang
Guangxin Wang
Lian Bai
Mingxue Zhao
Mingxue Zhao
Shumei Wang
author_facet Guangxin Wang
Guangxin Wang
Lian Bai
Mingxue Zhao
Mingxue Zhao
Shumei Wang
author_sort Guangxin Wang
collection DOAJ
description BackgroundA large number of papers regarding coronavirus disease 2019 (COVID-19) and epilepsy have been published since the declaration of the COVID-19 pandemic. However, there is no bibliometric analysis on these papers. In this study, we aimed to analyze the bibliometric characteristics of these papers, thus identifying the trends and future directions of COVID-19 and epilepsy research.MethodsScientific papers regarding COVID-19 and epilepsy were retrieved through searches of the Web of Science Core Collection database. Title, authors, contributing institute, country, source journal, times cited, and additional information were extracted from each selected paper. Microsoft Excel 2019 and GraphPad Prism 8 were used to analyze the extracted data and export the bar charts and tables whilst VOSviewer software was used to perform and visualize co-authorship analysis and co-occurrence analysis of keywords.ResultsA total of 317 papers regarding COVID-19 and epilepsy were included in the final analysis. Epilepsy & Behavior published the largest number of papers (n = 84). J. Helen Cross and Naoto Kuroda were the most prolific authors (n = 13 each). The United States (n = 88) and the University of London (n = 23) were the country and organization with the most contributions, respectively. The strongest authors' collaborations were between Giovanni Assenza and Jacopo Lanzone and between J. Helen Cross and Nathalie Jette. Selected author keywords were organized into seven clusters, and the keywords in clusters 1 and cluster 4 had the largest average appearing year of any clusters.ConclusionThis is the first bibliometric analysis of papers regarding COVID-19 and epilepsy. Our results showed that the United States was the leading country whilst J. Helen Cross was the most influential scholar in COVID-19 and epilepsy research. psychological consequences of COVID-19, and the safety of COVID-19 vaccines for people with epilepsy, are possible areas for future research on COVID-19 and epilepsy.
first_indexed 2024-04-12T11:49:25Z
format Article
id doaj.art-5fa2ffe102a44acda89ce84f537fa0bb
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-12T11:49:25Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-5fa2ffe102a44acda89ce84f537fa0bb2022-12-22T03:34:13ZengFrontiers Media S.A.Frontiers in Neurology1664-22952022-10-011310.3389/fneur.2022.10340701034070Global landscape of COVID-19 and epilepsy research: A bibliometric analysisGuangxin Wang0Guangxin Wang1Lian Bai2Mingxue Zhao3Mingxue Zhao4Shumei Wang5Shandong Innovation Center of Intelligent Diagnosis, Jinan Central Hospital, Shandong University, Jinan, ChinaDepartment of Pediatics, Central Hospital Affiliated to Shandong First Medical University, Jinan, ChinaGeneral Medical Department, Jinan Central Hospital, Shandong University, Jinan, ChinaShandong Innovation Center of Intelligent Diagnosis, Jinan Central Hospital, Shandong University, Jinan, ChinaDepartment of Pediatics, Central Hospital Affiliated to Shandong First Medical University, Jinan, ChinaGeneral Medical Department, Jinan Central Hospital, Shandong University, Jinan, ChinaBackgroundA large number of papers regarding coronavirus disease 2019 (COVID-19) and epilepsy have been published since the declaration of the COVID-19 pandemic. However, there is no bibliometric analysis on these papers. In this study, we aimed to analyze the bibliometric characteristics of these papers, thus identifying the trends and future directions of COVID-19 and epilepsy research.MethodsScientific papers regarding COVID-19 and epilepsy were retrieved through searches of the Web of Science Core Collection database. Title, authors, contributing institute, country, source journal, times cited, and additional information were extracted from each selected paper. Microsoft Excel 2019 and GraphPad Prism 8 were used to analyze the extracted data and export the bar charts and tables whilst VOSviewer software was used to perform and visualize co-authorship analysis and co-occurrence analysis of keywords.ResultsA total of 317 papers regarding COVID-19 and epilepsy were included in the final analysis. Epilepsy & Behavior published the largest number of papers (n = 84). J. Helen Cross and Naoto Kuroda were the most prolific authors (n = 13 each). The United States (n = 88) and the University of London (n = 23) were the country and organization with the most contributions, respectively. The strongest authors' collaborations were between Giovanni Assenza and Jacopo Lanzone and between J. Helen Cross and Nathalie Jette. Selected author keywords were organized into seven clusters, and the keywords in clusters 1 and cluster 4 had the largest average appearing year of any clusters.ConclusionThis is the first bibliometric analysis of papers regarding COVID-19 and epilepsy. Our results showed that the United States was the leading country whilst J. Helen Cross was the most influential scholar in COVID-19 and epilepsy research. psychological consequences of COVID-19, and the safety of COVID-19 vaccines for people with epilepsy, are possible areas for future research on COVID-19 and epilepsy.https://www.frontiersin.org/articles/10.3389/fneur.2022.1034070/fullCOVID-19epilepsybibliometric analysisWeb of ScienceVOSviewer software
spellingShingle Guangxin Wang
Guangxin Wang
Lian Bai
Mingxue Zhao
Mingxue Zhao
Shumei Wang
Global landscape of COVID-19 and epilepsy research: A bibliometric analysis
Frontiers in Neurology
COVID-19
epilepsy
bibliometric analysis
Web of Science
VOSviewer software
title Global landscape of COVID-19 and epilepsy research: A bibliometric analysis
title_full Global landscape of COVID-19 and epilepsy research: A bibliometric analysis
title_fullStr Global landscape of COVID-19 and epilepsy research: A bibliometric analysis
title_full_unstemmed Global landscape of COVID-19 and epilepsy research: A bibliometric analysis
title_short Global landscape of COVID-19 and epilepsy research: A bibliometric analysis
title_sort global landscape of covid 19 and epilepsy research a bibliometric analysis
topic COVID-19
epilepsy
bibliometric analysis
Web of Science
VOSviewer software
url https://www.frontiersin.org/articles/10.3389/fneur.2022.1034070/full
work_keys_str_mv AT guangxinwang globallandscapeofcovid19andepilepsyresearchabibliometricanalysis
AT guangxinwang globallandscapeofcovid19andepilepsyresearchabibliometricanalysis
AT lianbai globallandscapeofcovid19andepilepsyresearchabibliometricanalysis
AT mingxuezhao globallandscapeofcovid19andepilepsyresearchabibliometricanalysis
AT mingxuezhao globallandscapeofcovid19andepilepsyresearchabibliometricanalysis
AT shumeiwang globallandscapeofcovid19andepilepsyresearchabibliometricanalysis